Articles in this supplement focus on the global opioid crisis, including coverage of harm reduction approaches, health justice promotion, and lessons learned.
Resources and Tools
This guide offers considerations for how state agency staff can develop and maintain an accessible, HIV and opioid use disorder (OUD) service inventory. This guide can be used by state agency HIV and OUD staff to:
This package is a learning tool designed for health departments and community-based organizations newly offering syringe services programs (SSPs) with the purpose of indexing the materials needed for safer injection, what to offer at a syringe services program, and how to explain what materials a
In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
A recent study published in Drug and Alcohol Dependence found evidence for racial/ethnic disparities in buprenorphine distribution across the United States.
Transgender people and communities, including nonbinary people, have specific needs within harm reduction programs.
The HIV and OUD Service and Funding Matrices Template supports state health departments in identifying opportunities for enhanced coordination between HIV and OUD funding and service provision.
Clinicians can now access up-to-date evidence-based office-based addiction treatment recommendations for treating opioid use disorder (OUD) on a smartphone app.
This webinar companion guide provides information for the January 2021 Strengthening Systems of Care: Supporting People with HIV and Opioid Use Disorder following Incarceration webinar.